Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging

Fluorescent semiconductor nanocrystals (quantum dots [QDs]) are hypothesized to be excellent contrast agents for biomedical assays and imaging. A unique property of QDs is that their absorbance increases with increasing separation between excitation and emission wavelengths. Much of the enthusiasm f...

Full description

Bibliographic Details
Main Authors: Yong Taik Lim, Sungjee Kim, Akira Nakayama, Nathan E. Stott, Moungi G. Bawendi, John V. Frangioni
Format: Article
Language:English
Published: SAGE Publications 2003-01-01
Series:Molecular Imaging
Online Access:https://doi.org/10.1162/15353500200302163
_version_ 1797282159477653504
author Yong Taik Lim
Sungjee Kim
Akira Nakayama
Nathan E. Stott
Moungi G. Bawendi
John V. Frangioni
author_facet Yong Taik Lim
Sungjee Kim
Akira Nakayama
Nathan E. Stott
Moungi G. Bawendi
John V. Frangioni
author_sort Yong Taik Lim
collection DOAJ
description Fluorescent semiconductor nanocrystals (quantum dots [QDs]) are hypothesized to be excellent contrast agents for biomedical assays and imaging. A unique property of QDs is that their absorbance increases with increasing separation between excitation and emission wavelengths. Much of the enthusiasm for using QDs in vivo stems from this property, since photon yield should be proportional to the integral of the broadband absorption. In this study, we demonstrate that tissue scatter and absorbance can sometimes offset increasing QD absorption at bluer wavelengths, and counteract this potential advantage. By using a previously validated mathematical model, we explored the effects of tissue absorbance, tissue scatter, wavelength dependence of the scatter, water-to- hemoglobin ratio, and tissue thickness on QD performance. We conclude that when embedded in biological fluids and tissues, QD excitation wavelengths will often be quite constrained, and that excitation and emission wavelengths should be selected carefully based on the particular application. Based on our results, we produced near-infrared QDs optimized for imaging surface vasculature with white light excitation and a silicon CCD camera, and used them to image the coronary vasculature in vivo. Taken together, our data should prove useful in designing fluorescent QD contrast agents optimized for specific biomedical applications.
first_indexed 2024-03-07T17:08:59Z
format Article
id doaj.art-9b592e56f3e74e878f178bcc9db899f3
institution Directory Open Access Journal
issn 1536-0121
language English
last_indexed 2024-03-07T17:08:59Z
publishDate 2003-01-01
publisher SAGE Publications
record_format Article
series Molecular Imaging
spelling doaj.art-9b592e56f3e74e878f178bcc9db899f32024-03-03T02:19:43ZengSAGE PublicationsMolecular Imaging1536-01212003-01-01210.1162/1535350020030216310.1162_15353500200302163Selection of Quantum Dot Wavelengths for Biomedical Assays and ImagingYong Taik Lim0Sungjee Kim1Akira Nakayama2Nathan E. Stott3Moungi G. Bawendi4John V. Frangioni5Beth Israel Deaconess Medical CenterMassachusetts Institute of TechnologyBeth Israel Deaconess Medical CenterMassachusetts Institute of TechnologyMassachusetts Institute of TechnologyBeth Israel Deaconess Medical CenterFluorescent semiconductor nanocrystals (quantum dots [QDs]) are hypothesized to be excellent contrast agents for biomedical assays and imaging. A unique property of QDs is that their absorbance increases with increasing separation between excitation and emission wavelengths. Much of the enthusiasm for using QDs in vivo stems from this property, since photon yield should be proportional to the integral of the broadband absorption. In this study, we demonstrate that tissue scatter and absorbance can sometimes offset increasing QD absorption at bluer wavelengths, and counteract this potential advantage. By using a previously validated mathematical model, we explored the effects of tissue absorbance, tissue scatter, wavelength dependence of the scatter, water-to- hemoglobin ratio, and tissue thickness on QD performance. We conclude that when embedded in biological fluids and tissues, QD excitation wavelengths will often be quite constrained, and that excitation and emission wavelengths should be selected carefully based on the particular application. Based on our results, we produced near-infrared QDs optimized for imaging surface vasculature with white light excitation and a silicon CCD camera, and used them to image the coronary vasculature in vivo. Taken together, our data should prove useful in designing fluorescent QD contrast agents optimized for specific biomedical applications.https://doi.org/10.1162/15353500200302163
spellingShingle Yong Taik Lim
Sungjee Kim
Akira Nakayama
Nathan E. Stott
Moungi G. Bawendi
John V. Frangioni
Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging
Molecular Imaging
title Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging
title_full Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging
title_fullStr Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging
title_full_unstemmed Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging
title_short Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging
title_sort selection of quantum dot wavelengths for biomedical assays and imaging
url https://doi.org/10.1162/15353500200302163
work_keys_str_mv AT yongtaiklim selectionofquantumdotwavelengthsforbiomedicalassaysandimaging
AT sungjeekim selectionofquantumdotwavelengthsforbiomedicalassaysandimaging
AT akiranakayama selectionofquantumdotwavelengthsforbiomedicalassaysandimaging
AT nathanestott selectionofquantumdotwavelengthsforbiomedicalassaysandimaging
AT moungigbawendi selectionofquantumdotwavelengthsforbiomedicalassaysandimaging
AT johnvfrangioni selectionofquantumdotwavelengthsforbiomedicalassaysandimaging